Chatani M, Inoue T, Harada K, Inoue T, Suzuki R
Gan No Rinsho. 1983 Jun;29(7):771-6.
A randomized clinical trial of whole brain irradiation for brain metastases arising from lung cancer is in progress to improve survival and the quality of life. Between September 1980 and July 1982, 40 patients were treated using 4 MV X-ray. Concerning the radiation dose, laboratory tests and the physical condition of the patients, we analyzed 22 data items by means of quantification II, one of the methods of multivariate analysis. We found that neurologic function, performance status and LDH are important factors in assessing the 120-day survival.
一项关于全脑照射治疗肺癌脑转移的随机临床试验正在进行中,以提高生存率和生活质量。1980年9月至1982年7月期间,40例患者接受了4兆伏X射线治疗。关于辐射剂量、实验室检查和患者的身体状况,我们采用多变量分析方法之一的量化II分析了22个数据项。我们发现神经功能、身体状况和乳酸脱氢酶是评估120天生存率的重要因素。